Ewing-based Orcosa developed the The RITe Platform, which produces an easy-to-take orally disintegrating tablet that rapidly infuses an active ingredient through the tissue in the cheek – enabling therapeutic effects quickly and efficiently. In this episode of NJBIZ Conversations, co-founders Bryan Ridall and Vincent Mileto discuss Ocrosa's origins, the promise of its technology and where the life sciences company is headed next.
